PG logo

Procter & Gamble

PG · What the business does, what can go wrong, and how options sellers approach it

What it does

Procter & Gamble is a global consumer products company. It makes everyday household and personal care items and sells them under well-known brands in many countries.

Its products fall into broad categories such as fabric and home care (laundry detergent, dish soap), baby and family care (diapers, tissue and paper towels), beauty and grooming (shampoo, skin care, razors), and health care (oral care and over-the-counter products). Tide, Pampers, Charmin, Pantene and Gillette are examples of its brands.

How it makes money

P&G sells its products mainly to retailers such as supermarkets, mass merchandisers, drugstores and e-commerce platforms, which then sell to consumers. Revenue comes from the volume it sells and the prices it charges. It invests in advertising and innovation to support its brands and pricing.

Why investors own it

Demand for laundry soap, diapers and toothpaste tends to hold up in weak economies, so the business is often described as defensive. Investors also value its brand strength, global scale and long record of paying dividends.

What can go wrong

  • Rising costs for raw materials, packaging and transportation can squeeze profit margins.
  • Shoppers may trade down to cheaper store brands, especially when budgets are tight.
  • A strong U.S. dollar can reduce the value of overseas sales when converted back.
  • Large retailers hold bargaining power and can push back on prices.
  • A defensive reputation does not prevent the stock from falling, especially when interest rates rise or investors favor faster-growing sectors.

What to watch

  • Organic sales growth, which strips out currency and acquisitions
  • Volume versus pricing contributions to growth
  • Gross and operating margins
  • Commodity and freight cost trends
  • Management's annual sales and earnings outlook

Options income angle

Options on PG are typically liquid, with many strikes and expirations and fairly tight bid-ask spreads on the most active contracts. Implied volatility is usually lower than for the average stock, which means the premium collected is often modest.

Implied volatility tends to rise ahead of quarterly earnings reports, when the company updates its outlook, and during broad market stress.

One caution: low-volatility stocks can still gap on earnings or guidance changes.

What the latest 10-K says

A plain-English read of the Risk Factors and Management's Discussion in the 10-K for the year ended June 30, 2026, filed August 4, 2026. Figures are as the filing reports them. Read the filing on SEC.gov

The filing in brief

Procter & Gamble reported net sales up 3% to $87.0 billion for the fiscal year ended June 30, 2026, but the growth came from foreign exchange and pricing, not from selling more units. Operating income fell 3% to $19.7 billion as margins narrowed. Core EPS (earnings per share excluding items management calls non-recurring) rose 1% to $6.89. The company is midway through a restructuring plan and has agreed to buy Thorne for $3.8 billion.

How the business did

  • Net sales rose 3%, driven by favorable foreign exchange of 2% and pricing of 1%. Unit volume and mix were unchanged. Organic sales, which strip out acquisitions, divestitures and currency, increased 1%.
  • Operating margin fell to 22.7% from 24.3%. Gross margin fell 100 basis points to 50.2% (a basis point is one hundredth of a percentage point), with 120 basis points of drag from unfavorable product mix. Marketing spending also rose.
  • Net earnings rose $79 million to $16.1 billion. Diluted EPS was $6.62, up 2%. Results included an after-tax gain of $261 million from the end of the Glad joint venture. The prior year carried a non-cash charge tied to the Argentina exit.
  • Beauty net sales rose 7% to $16.0 billion, with organic sales up 5%. Baby, Feminine & Family Care organic sales fell 1%. Net earnings declined in all five reportable segments.
  • Operating cash flow was $19.6 billion, up 10%. Adjusted free cash flow was $15.8 billion, or 100% of adjusted net earnings. Financing activities used $14.5 billion, mainly dividends and treasury stock purchases.

Risks specific to this company

  • Operations outside the U.S. generate more than 50% of annual net sales. Greater China, the United Kingdom, Canada, Japan and Germany together made up approximately 21% of net sales, so currency swings, tariffs and trade controls matter.
  • Russia accounted for 1% of consolidated net sales, net earnings and net assets. The company says it may reduce or discontinue operations there, which could mean asset impairments or write-downs. It also names the Middle East conflict as a risk to energy costs and supply chains.
  • Sales run through a small number of large retail channels. The filing warns that consolidation among retailers and disputes over trade terms could squeeze margins or shelf space.
  • The Gillette brand intangible asset is carried at $12.8 billion, and its fair value exceeds carrying value by greater than 10%. The filing calls it susceptible to impairment after a $1.3 billion before-tax charge in fiscal 2024. A 25 basis-point rise in the discount rate would cut its estimated fair value by approximately 5%.
  • Input costs, including resins and pulp, and tariffs can pressure margins. Tariffs and recoveries cost 30 basis points of gross margin. The company paid approximately $200 million in IEEPA tariffs after the Supreme Court ruled them invalid, and it recognized recovery of half.
  • Some products depend on sole supplier or sole manufacturing plant arrangements, so losing one site or supplier could interrupt supply.

What management is watching

  • The portfolio and productivity plan, announced June 2025, is expected to cost approximately $1.5 to $2.0 billion before tax over two years. Over half was incurred in fiscal 2026. It includes cutting up to 7,000 non-manufacturing overhead personnel by the end of fiscal 2027.
  • The Thorne acquisition, a vitamins and supplements brand, is expected to close in the second quarter of fiscal year 2027, subject to regulatory approval.
  • The long-term targets are organic sales growth above market growth rates, Core EPS growth of mid-to-high single digits, and adjusted free cash flow productivity of 90% or greater.
  • Management points investors to organic sales growth, Core EPS and adjusted free cash flow productivity. These are non-GAAP measures, meaning they are not defined by standard accounting rules, and they feed executive pay.
  • Management expects to adapt its strategy to consumers using social media, streaming and AI-based search, to retailers building their own media platforms, and to shoppers weighing value after cumulative inflation.

What the latest 10-Q says

A plain-English read of Management's Discussion (and any new or changed risk factors) in the 10-Q for the quarter ended September 30, 2026, filed October 22, 2026. Figures are as the filing reports them. Read the filing on SEC.gov

The quarter in brief

Procter & Gamble's net sales rose 4.0% to $23.3 billion in the quarter ended September 30, 2026, with a unit volume increase of 2.4%. Margins narrowed, though. Gross margin fell 160 basis points to 49.8% of net sales (a basis point is one hundredth of a percentage point), so diluted EPS rose only 1% to $1.97.

How the business did

  • Sales and profit: Net sales were $23,276 million, up from $22,386 million a year earlier. Operating income rose 1% to $5,937 million, while net earnings fell 1% to $4,757 million. Core EPS, which leaves out restructuring costs above the company's normal level, rose 1% to $2.00. Organic sales, which exclude acquisitions, divestitures and currency effects, increased 4.0%.
  • What drove it: Sales growth came from unit volume of 2.4%, favorable geographic mix of 1.1% and higher pricing of 0.4%. Gross margin was pressured by 140 basis points of higher commodity costs, 140 basis points of product and packaging investments and 50 basis points of unfavorable product mix. Manufacturing productivity savings of 120 basis points and 50 basis points from lower tariff costs and recognized recoveries partly offset these. Total SG&A (selling, general and administrative) spending was unchanged at $5.7 billion.
  • Segments: Beauty net sales rose 6% to $4.4 billion. Fabric & Home Care rose 4% to $8.2 billion on a unit volume increase of 4%. Health Care net earnings rose 9% to $783 million even though unit volume decreased 3%, helped by pricing and mix. Baby, Feminine & Family Care net earnings fell 4% to $1.1 billion, with gross margin down 220 basis points on commodity costs and merchandising investments.
  • Cash flow: Operating cash flow was $5.8 billion and free cash flow (operating cash flow less capital spending) was $4.4 billion, or 93% of net earnings. Financing activities generated $1.1 billion of net cash, mainly from a net debt increase related to the Thorne acquisition, partly offset by dividends and treasury stock purchases. Current liabilities exceeded current assets by $12.5 billion, and the company expects to support short-term needs largely through cash from operations.

What management is watching

  • Restructuring plan: The company expects about $2.0 billion in before-tax restructuring costs over two years. Over half was incurred in fiscal 2026 and the remainder is expected in fiscal 2027. The plan includes a reduction of up to 7,000 non-manufacturing overhead personnel by the end of fiscal 2027.
  • Thorne acquisition: The company completed the purchase of Thorne, a premium vitamins and supplements brand, on October 1, 2026 for $3.9 billion in cash. Thorne joins Personal Health Care. Its results are not material and will be reported starting with the quarter ending December 31, 2026.
  • Cost and policy exposures: Management points to commodity and input costs (especially resins and pulp), foreign exchange, tariffs and government policy. It notes that price increases used to offset costs may reduce consumer purchases.
  • Measures highlighted: Management directs investors to organic sales growth, Core EPS, free cash flow and free cash flow productivity, alongside unit volume growth, net sales, net earnings, diluted EPS and operating cash flow.

Follow PG in Kortex

The Kortex app shows PG's price, options chain and IV rank, and answers your questions from live market data and SEC filings.

Free to download.

Learn the strategies

More stock briefs

For education only, not financial advice. Options involve risk and are not suitable for every investor.